Today, building a successful market access strategy for a healthcare product depends not only on the product’s effectiveness and safety. An expert understanding of the fast evolving regulatory framework and the economical criteria influencing authorities decision-making process is critical.

Beyond collecting clinical data to prove a product’s efficacy, manufacturers have to demonstrate how their products contribute to lowering overall treatment costs. Quantifying the cost benefit to the public purse is critical for the price setting process.

To better respond to the market changes caused by increasingly stringent regulations, healthcare manufacturers are putting Market Access at the core of their strategy, starting from the clinical development phase.

HMQ Partners supports you on all aspects of Pricing and Market Access throughout your product’s life cycle: from the clinical development phase to reimbursement and post-marketing follow-up.